The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial
Background: Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and …
Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional …
CE Amadi, FO Lawal, AC Mbakwem… - International journal of …, 2018 - Springer
Background Studies in international literature have shown that Community Pharmacists can
make considerable impact in controlling cardiovascular disease risk factors, especially …
make considerable impact in controlling cardiovascular disease risk factors, especially …
[HTML][HTML] A community pharmacy-based cardiovascular risk screening service implemented in Iran
Z Jahangard-Rafsanjani, N Hakimzadeh… - Pharmacy Practice …, 2017 - SciELO Espana
JAHANGARD-RAFSANJANI, Zahra et al. A community pharmacy-based cardiovascular risk
screening service implemented in Iran. Pharmacy Pract (Granada)[online]. 2017, vol. 15, n …
screening service implemented in Iran. Pharmacy Pract (Granada)[online]. 2017, vol. 15, n …
Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think?
HA Almansour, NM Aloudah… - … Policy and Practice, 2021 - Taylor & Francis
Background Cardiovascular disease (CVD) is an emerging contributor to national morbidity
and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an …
and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an …
[HTML][HTML] Repérage-dépistage ciblé du risque cardio-neurovasculaire en officine
P Aly, G Tempremant, S Houppermans… - Sante Publique, 2018 - cairn.info
Introduction: L'implication des pharmaciens d'officine dans le dépistage des maladies cardio-
neurovasculaires (MCNV) permettrait de renforcer la prévention du risque cardio …
neurovasculaires (MCNV) permettrait de renforcer la prévention du risque cardio …
[PDF][PDF] CARDIOVASCULAR RISK SCREENING SERVICES IN SUDANESE COMMUNITY PHARMACIES
SS MOHAMED, DA BALLAL - Asian J Pharm Clin Res, 2019 - academia.edu
Objectives: This study aims to investigate the Sudanese community pharmacists knowledge
and practice regarding cardiovascular disease (CVD) risk assessment services. Methods: A …
and practice regarding cardiovascular disease (CVD) risk assessment services. Methods: A …
Prevenção de AVC: Contributo dos Farmacêuticos para a saúde pública
SAF Cunha - 2017 - search.proquest.com
Introdução: A Fibrilhação Auricular (FA) é uma arritmia cardíaca responsável por um terço
dos Acidentes Vasculares Cerebrais (AVC) isquémicos. Objetivos: Explorar a viabilidade do …
dos Acidentes Vasculares Cerebrais (AVC) isquémicos. Objetivos: Explorar a viabilidade do …